[1]	Chen QY, Costa M. Arsenic:a global environmental challenge[J]. Annu Rev Pharmacol Toxicol, 2021, 61(1):47-63.DOI:10.1146/annurev-pharmtox-030220-013418. Cited in this article [1]

[2]	Podgorsk J, Berg M. Global threat of arsenic in groundwater[J]. Science, 2020, 368(6493):845-850.DOI:10.1126/science.aba1510. Cited in this article [1]

[3]

Zhang WY, Zhang XN, Zhang CG, et al. Spatial and temporal distribution of arsenic concentration in rural drinking water and health risk assessment in Northern China from 2013 to 2022:a case study of Inner Mongolia Autonomous Region[J]. BMC Public Health, 2024, 24(1):3529.DOI:10.1186/s12889-024-20776-3. Cited in this article [1]

[4]	Flores-Collado G, Merida-Ortega Á, Lopez-Carrillo L. Metal mixtures and adiposity indicators in women from Northern Mexico[J]. Biometals, 2025, 38(2):545-557.DOI:10.1007/s10534-024-00661-7. Cited in this article [1]

[5]	Hsu YH, Wu CY, Lee HL, et al. Combined effects of global DNA methylation,blood lead and total urinary arsenic levels on developmental delay in preschool children[J]. Environ Health, 2025, 24(1):2.DOI:10.1186/s12940-024-01151-6. Cited in this article [1]

[6]	Biswas P, Sahu AK, Sahoo SK, et al. Prevalence of chronic kidney disease and anemia in Hirakud Command Area,Odisha,India:unveiling the role of environmental toxicants[J]. J Nephrol, 2025, 38(2):563-577.DOI:10.1007/s40620-024-02169-2. Cited in this article [1]

[7]	Khanam T, Liang S, Xu S, et al. Arsenic exposure induces urinary metabolome disruption in Pakistani male population[J]. Chemosphere, 2023, 312:137228.DOI:10.1016/j.chemosphere.2022.137228. Cited in this article [2]

[8]	Liu Y, Li W, Zhang J, et al. Associations of arsenic exposure and arsenic metabolism with the risk of non-alcoholic fatty liver disease[J]. Int J Hyg Environ Health, 2024, 257:114342.DOI:10.1016/j.ijheh.2024.114342. Cited in this article [2]

[9]	Gonzalez-Martinez F, Johnson-Restrepo B, Quinones LA. Arsenic inorganic exposure,metabolism,genetic biomarkers and its impact on human health:a mini-review[J]. Toxicol Lett, 2024, 398:105-117.DOI:/10.1016/j.toxlet.2024.06.008. Cited in this article [1]

[10]	Nurchi VM, Djordjevic AB, Crisponi G, et al. Arsenic toxicity:molecular targets and therapeutic agents[J]. Biomolecules, 2020, 10(2):235.DOI:10.3390/biom10020235. Cited in this article [1]

[11]	Sultan MW, Qureshi F, Ahmed S, et al. A comprehensive review on arsenic contamination in groundwater:sources,detection,mitigation strategies and cost analysis[J]. Environ Res, 2025, 265:120457.DOI:10.1016/j.envres.2024.120457. Cited in this article [1]

[12]	Di SR, Wollschlager D, Blettner M, et al. Mortality risk associated to arsenic exposure after a major disaster.Results from the Manfredonia occupational cohort study 1976-2021[J]. Int J Hyg Environ Health, 2024, 261:114428.DOI:10.1016/j.ijheh.2024.114428. Cited in this article [1]

[13]	Liao PJ, Lee CH, Wang SL, et al. Low-to-moderate arsenic exposure and urothelial tract cancers with a long latent period of follow-up in an arseniasis area[J]. J Epidemiol Glob Health, 2023, 13(4):807-815.DOI:10.1007/s44197-023-00152-x. Cited in this article [1]

[14]	Li TF, Xu Z, Zhang K, et al. Effects and mechanisms of N6-methyladenosine RNA methylation in environmental pollutant-induced carcinogenesis[J]. Ecotoxicol Environ Saf, 2024, 277:116372.DOI:10.1016/j.ecoenv.2024.116372. Cited in this article [1]

[15]	Deng LJ, Deng WQ, Fan SR, et al. m6A modification:recent advances,anticancer targeted drug discovery and beyond[J]. Mol Cancer, 2022, 21:52.DOI:10.1186/s12943-022-01510-2. Cited in this article [1]

[16]	Sendinc E, Shi Y. RNA m6A methylation across the transcriptome[J]. Mol Cell, 2023, 83(3):428-441.DOI:10.1016/j.molcel.2023.01.006. Cited in this article [1]

[17]	Huang W, Chen TQ, Fang K, et al. N6-methyladenosine methyltransferases:functions,regulation,and clinical potential[J]. J Hematol Oncol, 2021, 14:117.DOI:10.1186/s13045-021-01129-8. Cited in this article [1]

[18]	Zhao YC, Shi YF, Shen HF, et al. m6A-binding proteins:the emerging crucial performers in epigenetics[J]. J Hematol Oncol, 2020, 13:35.DOI:10.1186/s13045-020-00872-8. Cited in this article [1]

[19]	Boffetta P, Zunarlli C, Borron C. Dose-response analysis of exposure to arsenic in drinking water and risk of skin lesions:a systematic review of the literature[J]. Dose Response, 2020, 18(4):1559325820957823.DOI:10.1177/1559325820957823. Cited in this article [1]

[20]	Chen H, Zhao T, Sun D, et al. Changes of RNA N6-methyladenosine in the hormesis effect induced by arsenite on human keratinocyte cells[J]. Toxicol In Vitro, 2019, 56:84-92.DOI:10.1016/j.tiv.2019.01.010. Cited in this article [1]

[21]	Zhao T, Li X, Sun D, et al. Oxidative stress:one potential factor for arsenite-induced increase of N6-methyladenosine in human keratinocytes[J]. Environ Toxicol Pharmacol, 2019, 69:95-103.DOI:10.1016/j.etap.2019.04.005. Cited in this article [1]

[22]	Man J, Zhang Q, Zhao T, et al. Oxidative stress induced by arsenite is involved in YTHDF2 phase separation[J]. Biol Trace Elem Res, 2024, 202(3):885-899.DOI:10.1007/s12011-023-03728-7. Cited in this article [1]

[23]	Teffera M, Veith AC, Rronnekleiv-Kelly S, et al. Diverse mechanisms by which chemical pollutant exposure alters gut microbiota metabolism and inflammation[J]. Environ Int, 2024, 190:108805.DOI:10.1016/j.envint.2024.108805. Cited in this article [1]

[24]	Yang F, Zhang A. Role of N6-methyladenosine RNA modification in the imbalanced inflammatory homeostasis of arsenic-induced skin lesions[J]. Environ Toxicol, 2022, 37(8):1831-1839.DOI:10.1002/tox.23530. Cited in this article [1]

[25]	Yang F, Zhang A. Involvement of METTL3 in arsenite-induced skin lesions by targeting the SOCS3/STAT3/Krt signaling pathway[J]. Environ Pollut, 2023, 316(2):120634.DOI:10.1016/j.envpol.2022.120634. Cited in this article [1]

[26]	Palma-Lara I, Martinez-Castillo M, Quintana-Perez JC, et al. Arsenic exposure:a public health problem leading to several cancers[J]. Regul Toxicol Pharmacol, 2020, 110:104539.DOI:10.1016/j.yrtph.2019.104539. Cited in this article [1]

[27]	Zhao T, Sun D, Zhao M, et al. N6-methyladenosine mediates arsenite-induced human keratinocyte transformation by suppressing P53 activation[J]. Environ Pollut, 2020, 259:113908.DOI:10.1016/j.envpol.2019.113908. Cited in this article [1]

[28]	Cui YH, Yang S, Wei J, et al. Autophagy of the m6A mRNA demethylase FTO is impaired by low-level arsenic exposure to promote tumorigenesis[J]. Nat Commun, 2021, 12(1):2183.DOI:10.1038/s41467-021-22469-6. Cited in this article [1]

[29]	Zhao T, Sun D, Xiong W, et al. N6-methyladenosine plays a dual role in arsenic carcinogenesis by temporal-specific control of core target AKT1[J]. J Hazard Mater, 2023, 445:130468.DOI:10.1016/j.jhazmat.2022.130468. Cited in this article [1]

[30]	Zhao T, Sun D, Long K, et al. N6-methyladenosine upregulates ribosome biogenesis in environmental carcinogenesis[J]. Sci Total Environ, 2023, 881:163428.DOI:10.1016/j.scitotenv.2023.163428. Cited in this article [2]

[31]	Zhao T, Sun D, Long K, et al. N6-methyladenosine promotes aberrant redox homeostasis required for arsenic carcinogenesis by controlling the adaptation of key antioxidant enzymes[J]. J Hazard Mater, 2024, 465:133329.DOI:10.1016/j.jhazmat.2023.133329. Cited in this article [1]

[32]	Zhang Q, Man J, Zhao T, et al. YTHDF2 promotes arsenic-induced malignant phenotypes by degrading PIDD1 mRNA in human keratinocytes[J]. Chem Biol Interact, 2024, 406:111352.DOI:10.1016/j.cbi.2024.111352. Cited in this article [2]

[33]

Zhao T, Xiong W, Cai J, et al. YTHDF2 phase separation promotes arsenic-induced keratinocyte transformation in a poly-m6A-dependent manner by inhibiting translational initiation of the key tumor suppressor PTEN[J]. J Hazard Mater, 2024, 480:136243.DOI:10.1016/j.jhazmat.2024.136243. Cited in this article [2]

[34]	Drobna Z, Walton FS, Paul DS, et al. Metabolism of arsenic in human liver:the role of membrane transporters[J]. Arch Toxicol, 2010, 84(1):3-16.DOI:10.1007/s00204-009-0499-7. Cited in this article [2]

[35]	Naujokas MF, Anderson B, Ahsan H, et al. The broad scope of health effects from chronic arsenic exposure:update on a worldwide public health problem[J]. Environ Health Perspect, 2013, 121(3):295-302.DOI:10.1289/ehp.1205875. Cited in this article [1]

[36]	Qiu T, Wu C, Yao X, et al. AS3MT facilitates NLRP3 inflammasome activation by m6A modification during arsenic-induced hepatic insulin resistance[J]. Cell Biol Toxicol, 2023, 39(5):2165-2181.DOI:10.1007/s10565-022-09703-7. Cited in this article [1]

[37]	Zhang J, Song J, Liu S, et al. m6A methylation-mediated PGC-1α contributes to ferroptosis via regulating GSTK1 in arsenic-induced hepatic insulin resistance[J]. Sci Total Environ, 2023, 905:167202.DOI:10.1016/j.scitotenv.2023.167202. Cited in this article [1]

[38]	Li H, Wu L, Ye F, et al. As3MT via consuming SAM is involved in arsenic-induced nonalcoholic fatty liver disease by blocking m6A-mediated miR-142-5p maturation[J]. Sci Total Environ, 2023, 892:164746.DOI:10.1016/j.scitotenv.2023.164746. Cited in this article [3]

[39]	Qiu T, Hou K, Zhang J, et al. Sodium arsenite induces hepatic stellate cells activation by m6A modification of TGF-β1 during liver fibrosis[J]. Ecotoxicol Environ Saf, 2024, 278:116435.DOI:10.1016/j.ecoenv.2024.116435. Cited in this article [3]

[40]	马文靓, 吕曼, 杨杰, 等. 砷致肝损伤作用机制的研究进展[J]. 中华地方病学杂志, 2021, 40(1):75-80.DOI:10.3760/cma.j.cn231583-20200905-00234. Cited in this article [1]

[41]	Issanov A, Adewusi B, Saint-Jacques N, et al. Arsenic in drinking water and lung cancer:a systematic review of 35 years of evidence[J]. Toxicol Appl Pharmacol, 2024, 483:116808.DOI:10.1016/j.taap.2024.116808. Cited in this article [1]

[42]	George CM, Brooks WA, Graziano JH, et al. Arsenic exposure is associated with pediatric pneumonia in rural Bangladesh:a case control study[J]. Environ Health, 2015, 14:83.DOI:10.1186/s12940-015-0069-9. Cited in this article [1]

[43]	Siddique AE, Rahman M, Hossain MI, et al. Association between chronic arsenic exposure and the characteristic features of asthma[J]. Chemosphere, 2020, 246:125790.DOI:10.1016/j.chemosphere.2019.125790. Cited in this article [1]

[44]	Ren C, Zhou Y, Liu W, et al. Paradoxical effects of arsenic in the lungs[J]. Environ Health Prev Med, 2021, 26(1):80.DOI:10.1186/s12199-021-00998-2. Cited in this article [1]

[45]	Zhang H, Chen Q, Han H, et al. SUMOylation modification of FTO facilitates oxidative damage response of arsenic by IGF2BP3 in an m6A-dependent manner[J]. J Hazard Mater, 2024, 472:134440.DOI:10.1016/j.jhazmat.2024.134440. Cited in this article [2]

[46]	Wang P, Xie D, Xiao T, et al. H3K18 lactylation promotes the progression of arsenite-related idiopathic pulmonary fibrosis via YTHDF1/m6A/NREP[J]. J Hazard Mater, 2024, 461:132582.DOI:10.1016/j.jhazmat.2023.132582. Cited in this article [3]

[47]	Gorski P, Bialas AJ, Piotrowski WJ. Aging lung:molecular drivers and impact on respiratory diseases-a narrative clinical review[J]. Antioxidants, 2024, 13(12):1480.DOI:10.3390/antiox13121480. Cited in this article [1]

[48]

Xiao T, Wang P, Wu M, et al. METTL3-regulated m6A modification of lncRNA E230001N04Rik is involved in myofibroblast differentiation in arsenic-induced pulmonary fibrosis through promoting senescence of lung epithelial cells[J]. J Hazard Mater, 2024, 480:136094.DOI:10.1016/j.jhazmat.2024.136094. Cited in this article [1]

[49]	Gu S, Sun D, Dai H, et al. N6-methyladenosine mediates the cellular proliferation and apoptosis via microRNAs in arsenite-transformed cells[J]. Toxicol Lett, 2018, 292:1-11.DOI:10.1016/j.toxlet.2018.04.018. Cited in this article [3]

[50]	Chen B, Wang L, Li L, et al. N6-methyladenosine facilitates arsenic-induced neoplastic phenotypes of human bronchial epithelial cells by promoting miR-106b-5p maturation[J]. Ecotoxicol Environ Saf, 2024, 283:116803.DOI:10.1016/j.ecoenv.2024.116803. Cited in this article [1]

[51]	Escudero-Lourdes C. Toxicity mechanisms of arsenic that are shared with neurodegenerative diseases and cognitive impairment:role of oxidative stress and inflammatory responses[J]. Neurotoxicology, 2016, 53:223-235.DOI:10.1016/j.neuro.2016.02.002. Cited in this article [1]

[52]	Garza-Lombo C, Pappa A, Panayiotidis MI, et al. Arsenic-induced neurotoxicity:a mechanistic appraisal[J]. J Biol Inorg Chem, 2019, 24(8):1305-1316.DOI:10.1007/s00775-019-01740-8. Cited in this article [2]

[53]	Bai L, Tang Q, Zou Z, et al. m6A demethylase FTO regulates dopaminergic neurotransmission deficits caused by arsenite[J]. Toxicol Sci, 2018, 165(2):431-446.DOI:10.1093/toxsci/kfy172. Cited in this article [2]

[54]	陈若楠, 虞子樱, 程淑群, 等. 中国毒理学会第十次全国毒理学大会论文集[C]. 珠海: 中国毒理学会, 2023.DOI:10.26914/c.cnkihy.2023.011850. Cited in this article [2]

[55]	王芳红, 李丹阳, 蔡学梅, 等. 中国毒理学会第十次全国毒理学大会论文集[C]. 珠海: 中国毒理学会, 2023.DOI:10.26914/c.cnkihy.2023.011784. Cited in this article [2]

[56]	Zhou L, Li R, Wang F, et al. N6-methyladenosine demethylase FTO regulates neuronal oxidative stress via YTHDC1-ATF3 axis in arsenic-induced cognitive dysfunction[J]. J Hazard Mater, 2024, 480:135736.DOI:10.1016/j.jhazmat.2024.135736. Cited in this article [2]

[57]	孙威, 李丹阳, 黄黎霜, 等. 中国毒理学会第十次全国毒理学大会论文集[C]. 珠海: 中国毒理学会, 2023.DOI:10.26914/c.cnkihy.2023.011785. Cited in this article [2]

[58]	何璎, 邹蔓姝, 韩远山, 等. 小胶质细胞活化介导的神经元损伤与抑郁症的研究进展[J]. 中国药理学通报, 2024, 40(1):12-15.DOI:10.12360/CPB202208029. Cited in this article [1]

[59]	Li M, Zhao X, Wang W, et al. Ythdf2-mediated m6A mRNA clearance modulates neural development in mice[J]. Genome Biol, 2018, 19(1):69.DOI:10.1186/s13059-018-1436-y. Cited in this article [1]

[60]	李秀娟, 杨丽红, 赵陶然, 等. 砷的胚胎发育毒性研究进展[J]. 生命的化学, 2020, 40(7):1041-1048.DOI:10.13488/j.smhx.20200127. Cited in this article [1]

[61]	夏雅娟, 旭日干, 刘东军. 砷的生殖发育毒性及雌激素效应研究进展[J]. 中国地方病学杂志, 2010, 29(1):112-115.DOI:10.3760/cma.j.issn.1000-4955.2010.01.036. Cited in this article [1]

[62]	Song YP, Lv JW, Zhang ZC, et al. Effects of gestational arsenic exposures on placental and fetal development in mice:the role of cyr61 m6A[J]. Environ Health Perspect, 2023, 131(9):97004.DOI:10.1289/ehp12207. Cited in this article [2]

[63]	陈益钦, 张文辉, 孙涵, 等. 中国毒理学会第十次全国毒理学大会论文集[C]. 珠海: 中国毒理学会, 2023.DOI:10.26914/c.cnkihy.2023.012420. Cited in this article [2]

[64]	Zhang T, Niu J, Ren T, et al. METTL3 prevents granulosa cells mitophagy by regulating YTHDF2-mediated BNIP3 mRNA degradation due to arsenic exposure[J]. Ecotoxicol Environ Saf, 2024, 286:117233.DOI:10.1016/j.ecoenv.2024.117233. Cited in this article [1]

[65]	Rahaman MS, Rahman MM, Mise N, et al. Environmental arsenic exposure and its contribution to human diseases,toxicity mechanism and management[J]. Environ Pollut, 2021, 289:117940.DOI:10.1016/j.envpol.2021.117940. Cited in this article [1]

[66]	Tyczynska M, Hunek G, Kawecka W, et al. Association between serum concentrations of metals and type 2 diabetes mellitus[J]. J Clin Med, 2024, 13(23):7443.DOI:10.3390/jcm13237443. Cited in this article [1]

[67]	Qiu T, Zhang J, Song J, et al. Arsenic inducible islet β-cell dysfunction and ferroptosis through m6A-YTHDF2-dependent CHAC1 enhancement[J]. Ecotoxicol Environ Saf, 2025, 289:117479.DOI:10.1016/j.ecoenv.2024.117479. Cited in this article [2]

[68]	卢朝虹, 陈若楠, 程淑群, 等. 中国毒理学会第十次全国毒理学大会论文集[C]. 珠海: 中国毒理学会, 2023.DOI:10.26914/c.cnkihy.2023.011880. Cited in this article [1]